Navigation Links
Darius Naigamwalla Appointed Senior Vice President and Head of the Brand Management Practice at Campbell Alliance
Date:8/7/2008

RALEIGH, N.C., Aug. 7 /PRNewswire/ -- Campbell Alliance, the leading management consulting firm specializing in the pharmaceutical and biotech industry, today announced that Darius Naigamwalla has been appointed Senior Vice President and head of the firm's Brand Management Practice. Mr. Naigamwalla replaces Nader Naeymi-Rad, who was recently promoted to Chief Operating Officer at the firm.

Mr. Naigamwalla has been a member of the Brand Management Practice since joining the firm in 2001. Since that time, he has worked across all service areas of the Brand Management Practice, from new product planning and market forecasting to commercial strategy development and launch excellence. Mr. Naigamwalla has helped dozens of companies in the United States, Canada, the United Kingdom, and Europe develop comprehensive commercial launch strategies across a range of therapeutic areas including cardiology, pulmonology, rheumatology, orthopedics, virology, hematology, hepatology, gastroenterology, critical care, nephrology, oncology, and endocrinology.

In his new role as the head of the Brand Management Practice, Mr. Naigamwalla will oversee the practice's complete operations in North America, the United Kingdom, and Europe.

"Darius is one of the most focused and disciplined individuals I've worked with over the span of my career in the pharmaceutical and biotech industry. Since his first year at Campbell Alliance, Darius has always been one of our most commonly requested consultants. He has developed and maintained an exceptional track record of client satisfaction-one of the founding principles and key success factors for the growth of Campbell Alliance overall. Regardless of the task at hand, Darius has consistently overcome significant obstacles to help meet the needs of our clients," stated John Campbell, CEO of Campbell Alliance.

Mr. Naigamwalla holds an MBA from the University of Victoria, an MS in biochemistry and molecular biology from the University of Western Ontario, and a BS (with honors) in biochemistry from McMaster University.

About Campbell Alliance

Campbell Alliance is the leading management consulting firm specializing in the pharmaceutical and biotechnology industry. The firm's clients include most of the world's top-20 pharmaceutical companies, as well as numerous emerging and midsize firms. Campbell Alliance is organized into practice areas, each specializing in a critical industry function: Brand Management, Business Development, Clinical Development, Managed Markets, Sales, and Trade and Distribution. From its locations in Raleigh, NC, Parsippany, NJ, Los Angeles, San Francisco, Chicago, Boston, Philadelphia, New York City, Atlanta, and London, the firm serves clients throughout North America, Europe, and Japan. For more information on Campbell Alliance, please visit http://www.campbellalliance.com .

CONTACT:

James Forte

Director, Public and Media Relations

Campbell Alliance

+1 919 844 7100, extension 7195

jforte@campbellalliance.com


'/>"/>
SOURCE Campbell Alliance
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Dr. Robert N. Butler Appointed to Board of Directors of BioTime, Inc.
2. William P. Sheridan Appointed Chief Medical Officer of BioCryst Pharmaceuticals
3. Lillys Connelly Appointed to the Presidents Commission on White House Fellowships
4. Graham Hetherington Appointed Chief Financial Officer and Board Director at Shire
5. James T. Glover Appointed to Board of Directors of Varian, Inc.
6. Frederic Desdouits Appointed Member of the Supervisory Board of ExonHit Therapeutics
7. Dr Michael Rosenblatt Appointed Non-Executive Director at Shire
8. Danong Chen appointed CEO of Theranostics Health
9. eBioscience Corporation Announced Today That James Glynn Has Been Appointed to Its Board of Directors, Effective April 15, 2008
10. W. Thomas Hodgson appointed to board of Helix BioPharma Corp.
11. Mercury Therapeutics, Inc: Marquant Appointed to Advise on Strategic and Partnering Opportunities
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/12/2017)... New York, NY (PRWEB) , ... October 12, ... ... York Academy of Sciences today announced the three Winners and six Finalists of ... Awards are given annually by the Blavatnik Family Foundation and administered by the ...
(Date:10/12/2017)... ... October 12, 2017 , ... BioMedGPS ... the addition of its newest module, US Hemostats & Sealants. , SmartTRAK’s US ... absorbable hemostats, fibrin sealants, synthetic sealants and biologic sealants used in surgical applications. ...
(Date:10/11/2017)... (PRWEB) , ... October 11, 2017 , ... ... Foundation President Andi Purple announced Dr. Suneel I. Sheikh, the co-founder, CEO ... ASTER Labs ), Inc. has been selected for membership in ARCS Alumni ...
(Date:10/11/2017)... ... October 11, 2017 , ... ComplianceOnline’s Medical Device Summit is back for ... June 2018 in San Francisco, CA. The Summit brings together current and former FDA ... board directors and government officials from around the world to address key issues in ...
Breaking Biology Technology:
(Date:4/11/2017)... DUBLIN , Apr. 11, 2017 Research ... Tracking Market 2017-2021" report to their offering. ... The global eye tracking market to grow at ... The report, Global Eye Tracking Market 2017-2021, has been prepared based ... report covers the market landscape and its growth prospects over the ...
(Date:4/6/2017)... , April 6, 2017 Forecasts ... ANPR, Document Readers, by End-Use (Transportation & Logistics, Government ... Oil, Gas & Fossil Generation Facility, Nuclear Power), Industrial, ... Other) Are you looking for a definitive ... ...
(Date:4/5/2017)... , April 4, 2017 KEY FINDINGS ... anticipated to expand at a CAGR of 25.76% during ... diseases is the primary factor for the growth of ... report: https://www.reportbuyer.com/product/4807905/ MARKET INSIGHTS The global ... product, technology, application, and geography. The stem cell market ...
Breaking Biology News(10 mins):